Picture of Orexo AB logo

ORX Orexo AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Orexo Submits New Drug Application To FDA For OX124, High-Dose Rescue Medication For Opioid Overdose

Feb 3 (Reuters) - Orexo AB  ORX.ST :
    * OREXO SUBMITS NEW DRUG APPLICATION TO FDA FOR OX124, A
HIGH-DOSE
RESCUE MEDICATION FOR OPIOID OVERDOSE
    * OX124 IS DESIGNED TO REVERSE EFFECTS OF MOST POWERFUL
SYNTHETIC
OPIOIDS, SUCH AS FENTANYL
    * IF APPROVED, US LAUNCH IS EXPECTED TO BE INITIATED IN H1
2024

Source text for Eikon:  ID:nWkr2p3D5t 
Further company coverage:  ORX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Orexo AB

See all news